Occupational asthma after inhalation of dust of the proteolytic enzyme, papain
- PMID: 1201257
- PMCID: PMC1008080
- DOI: 10.1136/oem.32.4.302
Occupational asthma after inhalation of dust of the proteolytic enzyme, papain
Abstract
Papain is a proteolytic enzyme widely used by biochemists. In experiments on animals papain has been shown to cause emphysema either when they inhaled a single small dose or after intratracheal inhalation. Four food technologists were occupationally exposed to heavy concentrations of papain dust in air. Subjects 1 and 2 developed an immediate acute asthmatic reaction, and symptoms of obstructive airways disease persisted for some months while each remained in the same working area, presumably exposed to small gradually diminishing amounts of residual papain dust. Tests of respiratory function were carried out on all four subjects 1 1/2 years later and showed in subjects 1 and 3 minimal abnormality of bronchial reactivity and of ventilation distribution. Review of the literature reveals only two reports of asthma resulting from papain inhalation, although its antigenic and skin sensitizing qualities have been known and described for many years. It seems remarkable that a substance such as papain, shown to be a potent cause of lung damage in experimental animals, should have produced so little evidence of abnormality in our subjects after considerable exposure. Follow-up ventilatory function tests may cast further light on this but we postulate that the asthmatic response may be biologically protective and those lacking this reaction could later develop emphysema as a long-term outcome.
Similar articles
-
Respiratory hazards from papain.Lancet. 1978 Feb 25;1(8061):430-2. doi: 10.1016/s0140-6736(78)91216-3. Lancet. 1978. PMID: 75454
-
Clinical symptoms and results of skin test, RAST and bronchial provocation test in thirty-three papain workers: evidence for strong immunogenic potency and clinically relevant 'proteolytic effects of airborne papain'.Clin Allergy. 1982 Jan;12(1):9-17. doi: 10.1111/j.1365-2222.1982.tb03121.x. Clin Allergy. 1982. PMID: 7039863
-
[Contact urticaria, rhinoconjunctivitis and bronchial asthma from occupational use of papain].Allergol Immunopathol (Madr). 1999 Sep-Oct;27(5):273-5. Allergol Immunopathol (Madr). 1999. PMID: 10568879 Spanish.
-
Why does airway obstruction persist in asthma due to low-molecular-weight agents? A Pathologistís view.Occup Med. 2000 Apr-Jun;15(2):445-54. Occup Med. 2000. PMID: 10769349 Review.
-
Prognosis of occupational asthma induced by isocyanates.Bull Eur Physiopathol Respir. 1987 Nov-Dec;23(6):565-9. Bull Eur Physiopathol Respir. 1987. PMID: 3331124 Review.
Cited by
-
Animal models of emphysema.Chin Med J (Engl). 2019 Oct 20;132(20):2465-2475. doi: 10.1097/CM9.0000000000000469. Chin Med J (Engl). 2019. PMID: 31567388 Free PMC article. Review.
-
Possible Crosstalk of the Immune Cells within the Lung and Mediastinal Fat-Associated Lymphoid Clusters in the Acute Inflammatory Lung Asthma-Like Mouse Model.Int J Mol Sci. 2021 Jun 26;22(13):6878. doi: 10.3390/ijms22136878. Int J Mol Sci. 2021. PMID: 34206847 Free PMC article.
-
Interleukin-33 and thymic stromal lymphopoietin, but not interleukin-25, are crucial for development of airway eosinophilia induced by chitin.Sci Rep. 2021 Mar 15;11(1):5913. doi: 10.1038/s41598-021-85277-4. Sci Rep. 2021. PMID: 33723298 Free PMC article.
-
IL-33 is a crucial amplifier of innate rather than acquired immunity.Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18581-6. doi: 10.1073/pnas.1003059107. Epub 2010 Oct 11. Proc Natl Acad Sci U S A. 2010. PMID: 20937871 Free PMC article.
-
Harnessing the Potential of Enzymes as Inhaled Therapeutics in Respiratory Tract Diseases: A Review of the Literature.Biomedicines. 2022 Jun 17;10(6):1440. doi: 10.3390/biomedicines10061440. Biomedicines. 2022. PMID: 35740461 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous